bigram | freq |
---|---|
abdominal aortic | 2 |
abdominal pain | 4 |
abdominal paracentesis | 2 |
abnormal uterine | 2 |
about benefits | 2 |
about life | 2 |
about risks | 4 |
about their | 3 |
above agents | 4 |
absence contraindications | 3 |
absence evidence | 2 |
absence other | 2 |
academy pediatrics | 4 |
accelerated radiation | 2 |
acceptable treatment | 2 |
according international | 2 |
account individual'advocate | 2 |
acellular pertussis | 2 |
acid supplementation | 2 |
acinetobacter species | 5 |
active against | 10 |
active ingredient | 2 |
activity against | 5 |
activity available | 2 |
activity part | 2 |
acute bronchitis | 3 |
acute coronary | 4 |
acute cough | 2 |
acute decompensated | 3 |
acute epididymitis | 2 |
acute myocardial | 2 |
acute respiratory | 2 |
acute stroke | 2 |
acute treatment | 2 |
acyclovir should | 2 |
addition considered | 2 |
addition patients | 2 |
additional risk | 3 |
adefovir dipivoxil | 2 |
adenomatous polyp | 2 |
adequate gramnegative | 2 |
adequate intake | 2 |
adequately weeks | 2 |
adherence therapy | 2 |
adjunctive inhaled | 2 |
adjunctive therapy | 7 |
adjuvant radiotherapy | 2 |
adjuvant therapy | 5 |
adjuvant treatment | 2 |
administer vaccination | 2 |
administered alone | 2 |
administered hours | 2 |
administered patients | 3 |
administered when | 2 |
admitted hospital | 3 |
adolescent immunization | 2 |
adolescents newly | 2 |
adolescents years | 2 |
adrenal mass | 3 |
adult patients | 6 |
adults recommended | 2 |
adults requesting | 2 |
adults risk | 3 |
advance directives | 2 |
advanced anthracyclinesensitive | 2 |
advanced colorectal | 2 |
advanced lung | 2 |
advanced metastatic | 4 |
advanced small | 2 |
advanced unresectable | 2 |
adverse effects | 6 |
adverse event | 2 |
adverse outcome | 2 |
advisory committee | 2 |
advocate clients | 2 |
aerobic activity | 2 |
aeruginosa other | 2 |
aeruginosa recommend | 3 |
affect treatment | 2 |
affected area | 2 |
affected pain | 2 |
african americans | 3 |
after cardiac | 2 |
after careful | 2 |
after cesarean | 2 |
after cessation | 2 |
after diagnosis | 2 |
after failure | 2 |
after holding | 2 |
after hours | 2 |
after informed | 2 |
after initiation | 2 |
after pregnancy | 2 |
after progression | 2 |
after treatment | 2 |
after trial | 2 |
after undergoing | 3 |
against aeruginosa | 3 |
against aminoglycoside | 2 |
against aureus | 3 |
against both | 2 |
against cardiotoxicity | 2 |
against gramnegative | 2 |
against moderate | 2 |
against mrsa | 3 |
against routine | 8 |
against screening | 2 |
against single | 2 |
against tetanus | 3 |
aged months | 2 |
aged years | 5 |
agent active | 5 |
agent being | 2 |
agents active | 2 |
agents adequate | 2 |
agents been | 2 |
agents should | 4 |
agents such | 2 |
agents treatment | 2 |
agents used | 4 |
ages years | 3 |
airflow parameter | 2 |
airway pressure | 2 |
airways disease | 2 |
alcohol abuse | 2 |
alcohol problems | 2 |
aldosterone antagonist | 3 |
aldosterone antagonists | 2 |
aldosterone receptor | 5 |
alone combination | 4 |
alone rather | 4 |
already being | 4 |
also consider | 2 |
also given | 2 |
also option | 2 |
also performed | 2 |
also recommended | 2 |
also used | 2 |
altered mental | 3 |
alternative agents | 2 |
alternative conventional | 2 |
alternative therapy | 2 |
alternatives inhibitors | 2 |
although there | 2 |
ambulatory class | 4 |
ambulatory unfractionated | 2 |
american academy | 4 |
americans nyha | 2 |
aminoglycoside monotherapy | 2 |
among patients | 2 |
among those | 2 |
ampicillin sulbactam | 2 |
analysis patients | 2 |
anaphylactic reaction | 2 |
anastrozole exemestane | 2 |
androgen deficiency | 2 |
androgen therapy | 2 |
anesthesia should | 3 |
angiotensin receptor | 2 |
angiotensin receptorneprilysin | 2 |
angiotensinconverting enzyme | 3 |
angiotensinreceptor blockers | 2 |
animal bites | 2 |
another cause | 2 |
antagonists recommended | 2 |
antagonists selected | 2 |
antenatal corticosteroids | 2 |
anthracycline adjuvant | 2 |
anthracycline therapy | 2 |
anthracyclinecontaining chemotherapy | 2 |
anthracyclinenaive patients | 2 |
anthracyclinesensitive cancer | 2 |
antibiotic active | 3 |
antibiotic activity | 3 |
antibiotic definitive | 2 |
antibiotic in | 2 |
antibiotic susceptibility | 2 |
antibiotic therapy | 10 |
antibiotic treatment | 3 |
antibiotics different | 2 |
antibiotics given | 2 |
antibiotics should | 2 |
antibiotics such | 2 |
antibody response | 2 |
anticipatory guidance | 2 |
anticoagulant agent | 2 |
anticoagulants should | 2 |
anticoagulation oral | 2 |
anticoagulation reasonable | 2 |
anticoagulation recommended | 2 |
antiepileptic drugs | 2 |
antihypertensive therapy | 2 |
antiinflammatory drugs | 3 |
antimicrobial agent | 2 |
antimicrobial resistance | 4 |
antimicrobial susceptibility | 3 |
antimicrobial therapy | 8 |
antiplatelet therapy | 2 |
antipseudomonal antibiotics | 2 |
antiretroviral therapy | 3 |
antistaphylococcal penicillin | 2 |
antithymidylate synthase | 2 |
anxiety disorders | 3 |
aortic aneurysm | 3 |
aortic stenosis | 2 |
aortic valve | 2 |
apap devices | 2 |
apixaban rivaroxaban | 2 |
apparent first | 2 |
appears safe | 2 |
approach should | 2 |
appropriate assessment | 2 |
appropriate information | 3 |
appropriate initial | 2 |
appropriate pain | 2 |
appropriate patients | 6 |
appropriate therapy | 3 |
appropriate training | 2 |
appropriately qualified | 2 |
appropriately trained | 3 |
approximately morbidity | 2 |
approximately weeks | 2 |
arbs reasonable | 2 |
arbs recommended | 2 |
aromatase inhibitors | 2 |
arterial blood | 2 |
artery bypass | 3 |
artery disease | 3 |
artery revascularization | 2 |
ascitic fluid | 2 |
aspergillus skin | 2 |
aspirates biopsies | 2 |
aspiration biopsy | 2 |
aspirin therapy | 2 |
assess fibrinolytic | 2 |
assess patient | 4 |
assess their | 2 |
assessed periodically | 2 |
assessment management | 4 |
assessment organizational | 2 |
assessment pain | 2 |
assessment reasonable | 2 |
assessment should | 5 |
associated conventionaldose | 2 |
associated related | 2 |
associated significant | 3 |
asthma should | 5 |
asthma symptoms | 2 |
asymptomatic bacteriuria | 2 |
asymptomatic children | 3 |
asymptomatic microscopic | 2 |
asymptomatic patient | 2 |
asymptomatic patients | 3 |
asymptomatic pregnant | 2 |
asymptomatic women | 2 |
atrial fibrillation | 2 |
atrial pressure | 3 |
atrial septal | 2 |
attain systolic | 2 |
attention should | 2 |
atypical thought | 2 |
aureus isolates | 4 |
availability programs | 2 |
available data | 2 |
available evidence | 2 |
available treatment | 2 |
average risk | 3 |
averagerisk patients | 2 |
aware risk | 2 |
aware their | 2 |
axis positive | 2 |
azole therapy | 2 |
back pain | 2 |
barriers education | 2 |
base deficit | 2 |
based patient | 2 |
based primarily | 2 |
based upon | 5 |
baseline staging | 3 |
basic life | 3 |
basis risk | 2 |
beam radiation | 2 |
beam radiotherapy | 2 |
because been | 2 |
because patient | 2 |
because potential | 2 |
because risk | 2 |
because there | 2 |
because they | 3 |
become pregnant | 2 |
becoming pregnant | 2 |
bedding clothing | 2 |
been conducted | 2 |
been described | 2 |
been detected | 2 |
been determined | 3 |
been established | 4 |
been excluded | 3 |
been isolated | 2 |
been previously | 3 |
been proven | 4 |
been reported | 2 |
been ruled | 2 |
been shown | 7 |
been studied | 2 |
been taking | 2 |
been treated | 3 |
been used | 3 |
before after | 2 |
before beginning | 2 |
before discharge | 2 |
before surgery | 3 |
begin approximately | 2 |
behavior should | 2 |
behavioral interventions | 3 |
being considered | 5 |
being treated | 15 |
beneficial adjunctive | 2 |
beneficial effect | 3 |
beneficial patients | 3 |
benefit associated | 2 |
benefits limitations | 2 |
benefits risks | 4 |
best initial | 3 |
best practice | 2 |
best practices | 2 |
best supportive | 3 |
beta blocker | 4 |
beta blockers | 8 |
better than | 2 |
between months | 2 |
between oral | 2 |
between patient | 3 |
bevacizumab based | 2 |
beyond weeks | 2 |
biopsies swabs | 2 |
biopsy poses | 2 |
biopsy radiographically | 2 |
biopsy recommended | 2 |
biopsy rule | 2 |
biopsy surgical | 2 |
birth after | 2 |
birth rate | 2 |
birth weight | 2 |
block type | 2 |
blockers aldosterone | 2 |
blockers proven | 2 |
blockers should | 2 |
blocking agents | 3 |
blocking drugs | 3 |
blood cell | 5 |
blood count | 2 |
blood cultures | 2 |
blood flow | 2 |
blood lead | 3 |
blood pressure | 24 |
blood test | 3 |
blood urea | 2 |
body mass | 2 |
body temperature | 2 |
body weight | 3 |
bolus followed | 2 |
bone disease | 2 |
bone metastases | 3 |
bone scanning | 3 |
both their | 2 |
brain metastases | 2 |
brain radiotherapy | 3 |
branch block | 3 |
breast cancer | 15 |
breast conservation | 2 |
breast examination | 5 |
breast irradiation | 3 |
breast selfexamination | 2 |
breastfeeding should | 2 |
bubonic plague | 2 |
bundle branch | 3 |
bypass graft | 2 |
bypass grafting | 2 |
calcineurin inhibitor | 2 |
calcium antagonist | 2 |
calcium channel | 5 |
calcium intake | 2 |
calcium magnesium | 2 |
calcium supplementation | 3 |
calcium vitamin | 2 |
caloric restriction | 2 |
cancer adenomatous | 2 |
cancer being | 2 |
cancer center | 2 |
cancer good | 2 |
cancer guideline | 3 |
cancer m | 4 |
cancer patients | 2 |
cancer risk | 2 |
cancer should | 6 |
cancer staging | 2 |
cancer surveillance | 2 |
cancer women | 2 |
candida parapsilosis | 2 |
candidates chemotherapy | 4 |
cannot administered | 2 |
cannot given | 2 |
cannot recommended | 5 |
cannot stabilized | 2 |
cannot used | 2 |
capecitabine combination | 3 |
carbapenemresistant pathogen | 2 |
carbuncles abscesses | 3 |
carcinoma cervix | 2 |
cardiac arrest | 3 |
cardiac death | 3 |
cardiac disease | 2 |
cardiac output | 4 |
cardiac transplantation | 6 |
cardiac troponin | 4 |
cardioembolic source | 2 |
cardioembolic stroke | 3 |
cardiorespiratory monitoring | 3 |
cardiotoxicity associated | 2 |
cardiovascular disease | 6 |
cardiovascular risk | 4 |
care clinician | 3 |
care including | 2 |
care needs | 2 |
care patients | 2 |
care physician | 2 |
care professionals | 3 |
care provider | 2 |
care providers | 4 |
care resources | 2 |
care services | 2 |
care setting | 2 |
care should | 5 |
care transitions | 2 |
care unit | 4 |
careful candidate | 2 |
carefully selected | 4 |
carefully selecteda | 2 |
caregivers should | 2 |
carer should | 2 |
carers should | 2 |
cases tularemia | 2 |
cause cough | 2 |
caused acinetobacter | 5 |
caused carbapenemresistant | 2 |
causes segment | 2 |
cd lymphocyte | 2 |
cefazolin preferred | 4 |
cefepime levofloxacin | 3 |
celiac disease | 2 |
cell count | 4 |
cell lung | 14 |
cell transfusion | 2 |
cellmediated immunodeficiency | 2 |
cells mm3 | 3 |
centred care | 2 |
cerebral palsy | 2 |
certain patients | 2 |
cervical cancer | 4 |
cervical ripening | 3 |
cesarean delivery | 5 |
change clinical | 2 |
channel blockers | 2 |
characteristics including | 2 |
characteristics recommended | 2 |
chemotherapy administered | 2 |
chemotherapy indicated | 2 |
chemotherapy m | 2 |
chemotherapy neutropenia | 2 |
chemotherapy radiotherapy | 4 |
chemotherapy recommended | 2 |
chemotherapy regimen | 4 |
chemotherapy should | 3 |
chest radiograph | 6 |
chest radiography | 4 |
chest scan | 2 |
child adolescent | 2 |
child family | 4 |
child risk | 2 |
child will | 2 |
children adolescents | 9 |
children adults | 2 |
children aged | 3 |
children chronic | 2 |
children developmental | 3 |
children epilepsy | 2 |
children experience | 2 |
children families | 2 |
children first | 2 |
children otitis | 2 |
children years | 5 |
choice antibiotic | 2 |
choice should | 3 |
choice treatment | 4 |
cholesterol highdensity | 2 |
cholesterol triglycerides | 2 |
chorionic gonadotropin | 2 |
chronic abdominal | 2 |
chronic anticoagulation | 2 |
chronic cough | 11 |
chronic hepatitis | 2 |
chronic hfref | 7 |
chronic lymphocytic | 2 |
chronic metabolic | 2 |
chronic obstructive | 3 |
chronic oral | 2 |
chronic pain | 3 |
chronic permanent | 3 |
cisplatinbased combination | 2 |
class ambulatory | 4 |
class lvef | 4 |
class studies | 3 |
class symptoms | 9 |
client centred | 2 |
clients should | 2 |
clindamycin recommended | 2 |
clinical appearance | 2 |
clinical assessment | 2 |
clinical breast | 6 |
clinical characteristics | 2 |
clinical condition | 2 |
clinical conditions | 2 |
clinical criteria | 5 |
clinical evaluationwomen | 3 |
clinical evidence | 3 |
clinical features | 2 |
clinical findings | 2 |
clinical grounds | 3 |
clinical judgement | 2 |
clinical judgment | 2 |
clinical laboratory | 2 |
clinical practice | 6 |
clinical presentation | 3 |
clinical response | 2 |
clinical setting | 2 |
clinical signs | 3 |
clinical situation | 2 |
clinical status | 4 |
clinical strategy | 2 |
clinical studies | 4 |
clinical suspicion | 3 |
clinical syndrome | 2 |
clinical trial | 4 |
clinical trials | 6 |
clinically operable | 2 |
clinician responsible | 3 |
clinician should | 5 |
clinicians consider | 2 |
clinicians considering | 3 |
clinicians screen | 3 |
clinicians should | 26 |
clinics officebased | 2 |
close attention | 2 |
close contacts | 2 |
cognitive function | 2 |
cognitive impairment | 3 |
colistin polymyxin | 3 |
colon cancer | 5 |
colonystimulating factor | 3 |
colonystimulating factors | 2 |
colorectal cancer | 7 |
combination chemotherapy | 6 |
combination docetaxel | 3 |
combination fluoropyrimidine | 2 |
combination gemcitabine | 2 |
combination hydralazine | 4 |
combination rituximab | 2 |
combination therapy | 7 |
commissioners should | 2 |
common causes | 3 |
common cold | 2 |
common etiologies | 2 |
commonly used | 3 |
community resources | 2 |
community such | 2 |
comorbid conditions | 6 |
complete blood | 3 |
complex partial | 2 |
complications should | 2 |
comprehensive assessment | 4 |
comprehensive history | 2 |
compression placed | 2 |
computed tomography | 10 |
concludes evidence | 7 |
concludes there | 3 |
concomitant estrogen | 2 |
confirm presence | 2 |
confirmed cutaneous | 2 |
congestive heart | 2 |
congestive symptoms | 3 |
conjunction evidencebased | 2 |
consensus expert | 2 |
consent should | 2 |
conservation surgery | 2 |
consider additional | 2 |
consider their | 2 |
consideration should | 2 |
considered acute | 2 |
considered adjuvant | 4 |
considered after | 2 |
considered appropriate | 3 |
considered candidates | 2 |
considered children | 2 |
considered decrease | 2 |
considered high | 4 |
considered monotherapy | 2 |
considered only | 2 |
considered patients | 18 |
considered persistently | 2 |
considered potentially | 2 |
considered reduce | 2 |
considered risk | 3 |
considered secondline | 2 |
considered treatment | 6 |
considered useful | 2 |
considered when | 3 |
considering laboratory | 3 |
contiguous limb | 2 |
contiguous precordial | 2 |
continued anthracyclinecontaining | 2 |
continued postoperatively | 2 |
continued until | 4 |
continuing education | 2 |
continuous intravenous | 3 |
continuous positive | 2 |
contraindicated reduce | 5 |
contraindications anticoagulation | 3 |
contribute implementation | 2 |
control survival | 2 |
controlled accordance | 2 |
controlled asthma | 2 |
controlled research | 2 |
controlled trial | 4 |
controlled trials | 6 |
cooperative oncology | 2 |
cord injury | 2 |
coronary anatomy | 2 |
coronary arteriography | 2 |
coronary artery | 6 |
coronary heart | 2 |
coronary revascularization | 2 |
coronary syndrome | 3 |
correct deficiencies | 2 |
correctional facility | 2 |
corticosteroid therapy | 3 |
corticosteroids followed | 2 |
cost tolerability | 2 |
cough apparent | 2 |
cough asthma | 2 |
cough nonasthmatic | 2 |
cough secondary | 2 |
cough should | 5 |
cough suppressants | 3 |
could considered | 6 |
could used | 2 |
counseled about | 2 |
counseled their | 2 |
counseling should | 2 |
count cells | 3 |
counts cells | 2 |
course antimicrobial | 2 |
coverage above | 2 |
coverage mrsa | 2 |
coverage mssa | 3 |
creatinine glucose | 2 |
creatinine levels | 2 |
criteria alone | 5 |
criteria decide | 4 |
critical aortic | 2 |
critical illness | 2 |
cryptogenic stroke | 2 |
ctfphc concludes | 3 |
culture exudates | 2 |
cultures blood | 3 |
curative intent | 2 |
current prior | 8 |
current recommendations | 2 |
current symptoms | 2 |
currently available | 2 |
currently recommended | 3 |
cutaneous aspirates | 2 |
cutaneous disseminated | 2 |
cyclophosphamide doxorubicin | 3 |
dabigatran apixaban | 2 |
daily calcium | 2 |
daily days | 5 |
daily dose | 2 |
daily lifestyle | 2 |
data available | 2 |
data concerning | 2 |
data safety | 2 |
data support | 3 |
days after | 8 |
days post | 3 |
days recommended | 4 |
daytime sleepiness | 2 |
decide whether | 4 |
decision about | 2 |
decision making | 2 |
decision regarding | 2 |
decision should | 2 |
decision whether | 2 |
decisions about | 2 |
decisions regarding | 2 |
decompensated should | 2 |
decrease hospitalizations | 3 |
dedication qualified | 2 |
deep vein | 3 |
deficiencies recommended | 2 |
definitive treatment | 2 |
dehydration fluid | 2 |
delivery should | 3 |
delivery transverse | 2 |
density lipoprotein | 4 |
department immediately | 3 |
depressed cardiac | 2 |
depression scale | 2 |
designed controlled | 2 |
designed improve | 2 |
despite gdmt | 2 |
despite initial | 2 |
despite optimal | 2 |
determine adequacy | 2 |
determine effectiveness | 2 |
determine presence | 2 |
determine prognosis | 2 |
determined clinical | 2 |
develop plan | 2 |
developers recommend | 14 |
developers suggest | 10 |
developing type | 2 |
development progression | 3 |
developmental assessment | 2 |
developmental delay | 2 |
developmental difficulties | 2 |
device therapy | 3 |
devices appropriate | 2 |
dexamethasone should | 2 |
dexrazoxane protect | 2 |
dexrazoxane recommended | 2 |
dexrazoxane when | 2 |
diabetes admitted | 2 |
diabetes mellitus | 8 |
diabetes progression | 2 |
diabetic foot | 2 |
diagnose epileptic | 3 |
diagnosis acute | 2 |
diagnosis exclusion | 2 |
diagnosis primary | 2 |
diagnosis should | 3 |
diagnosis treatment | 2 |
diagnostic evaluation | 4 |
diagnostic tests | 2 |
diagnostic workup | 2 |
diastolic blood | 4 |
diet exercise | 2 |
diet make | 2 |
dietary intake | 3 |
different classes | 2 |
differential diagnosis | 2 |
dinitrate recommended | 2 |
dinitrate useful | 2 |
diphtheria pertussis | 4 |
diphtheria tetanus | 2 |
diphtheria toxoids | 3 |
dipivoxil should | 2 |
direct contact | 2 |
direct indirect | 3 |
directives should | 2 |
directly related | 2 |
discharge planning | 3 |
discontinuation antibiotic | 2 |
discussed patient | 2 |
discussion between | 4 |
discussion education | 2 |
discussion should | 3 |
disease asthma | 2 |
disease cannot | 2 |
disease control | 2 |
disease failed | 2 |
disease important | 2 |
disease patient | 2 |
disease patients | 2 |
disease present | 2 |
disease progression | 3 |
disease severity | 2 |
disease should | 4 |
disease well | 2 |
disorders should | 3 |
disseminated infection | 3 |
distant metastatic | 2 |
distantsite palliative | 2 |
diuretic therapy | 4 |
diuretics recommended | 2 |
diuretics should | 2 |
diuretics vasodilators | 2 |
docetaxel capecitabine | 3 |
docetaxel m2 | 5 |
documented severe | 2 |
does appear | 2 |
does preclude | 2 |
does require | 2 |
does respond | 2 |
done after | 3 |
dose aspirin | 2 |
dose generally | 2 |
dose increase | 2 |
dose m2 | 3 |
dose tdap | 5 |
dose when | 2 |
doses schedules | 2 |
dosing should | 2 |
doxorubicin vincristine | 2 |
doxycycline recommended | 2 |
drainage should | 2 |
drawal symptoms | 3 |
drug interactions | 2 |
drug regimen | 3 |
drug therapy | 4 |
drug treatment | 5 |
drugs including | 2 |
drugs known | 2 |
drugs potentially | 2 |
drugs recommended | 2 |
drugs should | 3 |
drugs such | 2 |
duration nyha | 5 |
duration treatment | 2 |
during course | 2 |
during initial | 3 |
during treatment | 3 |
dysfunction significant | 2 |
each drug | 2 |
each patient | 8 |
each visit | 3 |
early childhood | 2 |
early course | 2 |
early defibrillation | 2 |
early detection | 2 |
early oestrogenreceptorpositive | 2 |
early postoperative | 2 |
early repolarization | 2 |
early tracheostomy | 3 |
eastern cooperative | 2 |
eating disorders | 4 |
ecog level | 2 |
ectopic pregnancy | 2 |
educated about | 2 |
education implementation | 2 |
education involvement | 2 |
education programmes | 2 |
education programs | 3 |
education reinforce | 2 |
education should | 2 |
educational health | 2 |
effective against | 2 |
effective care | 2 |
effective option | 2 |
effective patients | 2 |
effective reducing | 2 |
effective shortterm | 2 |
effective should | 3 |
effective treatment | 4 |
effects externalbeam | 2 |
effects however | 2 |
effects longterm | 2 |
effects occur | 2 |
efficacy recommended | 2 |
efficacy testosterone | 2 |
efforts should | 2 |
effusion should | 2 |
either alone | 3 |
either oral | 2 |
either vancomycin | 2 |
ejection fraction | 2 |
elderly patients | 2 |
electrolyte imbalance | 3 |
elevated blood | 4 |
elevated serum | 3 |
elevation early | 2 |
elevations greater | 2 |
eligible revascularization | 2 |
emergency contraception | 3 |
emergency department | 10 |
emergency tracheal | 2 |
emission tomography | 3 |
empiric coverage | 4 |
empiric therapy | 3 |
empiric treatment | 8 |
empirically recommend | 3 |
encourage patients | 2 |
encourage support | 2 |
endometrial cancer | 3 |
endomyocardial biopsy | 2 |
endoscopic general | 2 |
endoscopic procedures | 2 |
endoscopic surgeon | 2 |
endovaginal ultrasound | 2 |
enlarged mediastinal | 2 |
enoxaparin administered | 2 |
ensure adequate | 3 |
ensure onset | 2 |
environmental conditions | 2 |
enzyme inhibitor | 2 |
enzymeinducing antibiotics | 3 |
eosinophilic bronchitis | 3 |
epidermoid cysts | 2 |
epilepsy surgery | 2 |
epileptic seizures | 4 |
equal millivolts | 2 |
equal more | 2 |
erlotinib available | 2 |
erythropoietin recommended | 3 |
esophageal recording | 3 |
especially patients | 2 |
establishing diagnosis | 3 |
estimated glomerular | 3 |
estrogen therapy | 3 |
evaluate effectiveness | 2 |
evaluation patients | 6 |
evaluation should | 3 |
evaluation treatment | 2 |
even they | 2 |
even though | 3 |
even when | 3 |
event after | 2 |
event cardioembolic | 2 |
every hours | 4 |
every months | 3 |
every patient | 2 |
every three | 7 |
every weeks | 4 |
every years | 8 |
evidence does | 3 |
evidence insufficient | 7 |
evidence recommend | 8 |
evidence regarding | 2 |
evidence single | 2 |
evidence support | 5 |
evidence supporting | 3 |
evidence supports | 2 |
evidence their | 2 |
evidence time | 3 |
evidencebased beta | 3 |
examination focal | 2 |
examination should | 5 |
examinations should | 2 |
except palliation | 2 |
except when | 2 |
exclude other | 2 |
exemestane letrozole | 2 |
expectant management | 2 |
expectation meaningful | 2 |
expected unexpected | 2 |
experienced adverse | 2 |
external beam | 4 |
external radiation | 2 |
externalbeam radiation | 2 |
exudates skin | 2 |
factor antimicrobial | 2 |
factor cardioembolic | 3 |
factors antimicrobial | 2 |
factors cost | 2 |
factors guideline | 2 |
factors including | 2 |
factors mrsa | 2 |
factors such | 3 |
fail respond | 2 |
family history | 5 |
family members | 3 |
family structure | 2 |
familycentered care | 2 |
fasting lipid | 3 |
fasting triglycerides | 3 |
features infarction | 2 |
female patients | 2 |
fever neutropenia | 3 |
fewer than | 3 |
fibrinolytic therapy | 3 |
filtration rate | 4 |
finding isolated | 2 |
findings normal | 2 |
fire alarm | 2 |
first days | 2 |
first hours | 2 |
first line | 3 |
first step | 2 |
first trimester | 2 |
first unprovoked | 3 |
first years | 2 |
firstline chemotherapy | 3 |
firstline therapy | 8 |
firstline treatment | 4 |
five years | 2 |
flexible sigmoidoscopy | 3 |
fluid electrolyte | 4 |
fluid electrolytes | 2 |
fluid intake | 2 |
fluid overload | 2 |
fluid retention | 3 |
fluid should | 2 |
focal deficit | 2 |
folic acid | 3 |
followed inhaled | 2 |
following lumbar | 3 |
following recommendations | 3 |
following risk | 2 |
following three | 2 |
food intake | 2 |
foot infections | 2 |
force concludes | 2 |
force recommends | 5 |
force suggests | 2 |
formal nutrition | 2 |
formulation amphotericin | 3 |
found chest | 2 |
four months | 2 |
four weeks | 3 |
fractionation schedules | 2 |
fracture risk | 3 |
full discussion | 3 |
full dose | 2 |
fully ambulatory | 2 |
fully into | 2 |
function tests | 6 |
functional abdominal | 2 |
functional capacity | 3 |
functional class | 3 |
functional status | 7 |
further assessment | 2 |
further evaluation | 3 |
further research | 2 |
further studies | 2 |
further study | 2 |
further treatment | 4 |
fusion surgery | 2 |
gastroesophageal reflux | 2 |
gastrointestinal side | 2 |
gastrointestinal symptoms | 2 |
gastrointestinal tract | 2 |
gdmt device | 3 |
gdmt reasonable | 2 |
gdmt titrated | 2 |
general population | 3 |
general practitioners | 2 |
general surgeon | 2 |
generally high | 2 |
generally should | 4 |
generally used | 2 |
genetic testing | 2 |
geriatric depression | 2 |
gestational diabetes | 2 |
give hospital | 2 |
given before | 2 |
glasgow coma | 2 |
glomerular filtration | 4 |
goal achieving | 2 |
good functional | 2 |
good performance | 7 |
gram stain | 6 |
gramnegative activity | 2 |
gramnegative bacilli | 5 |
gramnegative isolates | 2 |
granulocyte colonystimulating | 3 |
greater than | 15 |
grounds out | 2 |
guide discontinuation | 2 |
guideline developers | 23 |
guideline document | 5 |
guideline treatment | 2 |
gynecologic surgery | 3 |
hand decontamination | 2 |
harmful patients | 3 |
head lice | 2 |
head neck | 3 |
health care | 14 |
health maintenance | 2 |
health practitioners | 2 |
health problems | 2 |
health professionals | 4 |
health reviews | 2 |
health support | 2 |
healthcare facilities | 2 |
healthcare professional | 4 |
healthcare team | 4 |
healthy individuals | 2 |
heart association | 3 |
heart disease | 5 |
heart failure | 8 |
heart rate | 5 |
heart valves | 2 |
helicobacter pylori | 2 |
hematologist oncologist | 2 |
hemodynamic instability | 2 |
hemodynamic monitoring | 3 |
hemoglobin levels | 2 |
heparin administered | 2 |
hepatitis infection | 2 |
hepatitis vaccination | 2 |
hepatocellular carcinoma | 2 |
herpes simplex | 2 |
hfref cannot | 2 |
hfref current | 2 |
hfref except | 2 |
hfref gdmt | 2 |
hfref hfpef | 2 |
hfref nyha | 2 |
hfref out | 2 |
hfref reduce | 3 |
hfref unless | 2 |
high prevalence | 2 |
high quality | 4 |
high risk | 30 |
high sensitivity | 2 |
highdensity lipoprotein | 4 |
higher doses | 3 |
higher risk | 2 |
highrisk chronic | 2 |
highrisk patients | 3 |
histological classification | 2 |
history acute | 3 |
history cancer | 3 |
history physical | 6 |
history previous | 2 |
history recurrent | 2 |
history should | 2 |
history substance | 2 |
history thrombosis | 2 |
hold treatment | 2 |
holding antisecretory | 2 |
home cardiorespiratory | 3 |
home care | 3 |
home haemodialysis | 2 |
hormonal therapies | 2 |
hormone replacement | 2 |
hormone therapy | 2 |
hospital discharge | 3 |
hospital satellite | 2 |
hospital should | 3 |
hospitalized patients | 3 |
hospitals clinics | 2 |
hour every | 3 |
hours after | 6 |
hours before | 3 |
hours guideline | 2 |
hours onset | 2 |
hours symptom | 3 |
however because | 2 |
however there | 2 |
human chorionic | 2 |
human immunodeficiency | 9 |
hydralazine isosorbide | 4 |
hyperbaric oxygen | 2 |
hyperfractionated accelerated | 2 |
hyperkalemia renal | 2 |
hypertension diabetes | 2 |
hypertension should | 3 |
hypertrophy incomplete | 2 |
identified clients | 2 |
identified individual | 2 |
identify patients | 3 |
identify risk | 2 |
identify whether | 2 |
ienf density | 2 |
iiia inhibitor | 2 |
iiia lung | 2 |
illicit substances | 2 |
imaging recommended | 3 |
imipenem meropenem | 4 |
immediately available | 2 |
immersion injuries | 2 |
immune deficiency | 2 |
immunization practices | 2 |
immunodeficiency immersion | 2 |
immunodeficiency virus | 8 |
immunosuppressive regimen | 3 |
impair quality | 2 |
impaired perfusion | 2 |
impetigo ecthyma | 3 |
impetigo should | 2 |
implantable cardioverterdefibrillator | 2 |
implementation includes | 2 |
implementation process | 2 |
implementation programme | 2 |
importance best | 2 |
important step | 2 |
improve functional | 3 |
improve live | 2 |
improve morbidity | 2 |
improve quality | 3 |
improve survival | 3 |
improve symptoms | 2 |
improvement programs | 2 |
improves survival | 2 |
improving quality | 3 |
in days | 7 |
in hours | 11 |
in their | 4 |
in weeks | 3 |
inactivated influenza | 2 |
incidence diabetes | 2 |
incision candidates | 2 |
incision drainage | 5 |
includes assessment | 3 |
includes coverage | 3 |
including agent | 2 |
including piperacillintazobactam | 3 |
including time | 2 |
incomplete bundle | 2 |
incorporated into | 2 |
increase daily | 2 |
increase decrease | 2 |
increase likelihood | 2 |
increase risk | 3 |
increased intracranial | 2 |
increased likelihood | 2 |
increased risk | 12 |
indicated opinion | 2 |
indicated part | 2 |
indicated patients | 6 |
indicated should | 3 |
indicated suggest | 3 |
indicated tolerated | 2 |
indications recommended | 2 |
indications splenectomy | 2 |
indirect supportive | 2 |
individual clinician | 3 |
individual provide | 2 |
individual should | 2 |
individual therapeutic | 2 |
individual'advocate carer | 2 |
individualized basis | 3 |
individuals out | 3 |
individuals should | 2 |
induction chemotherapy | 2 |
induction labor | 2 |
indwelling catheter | 2 |
infantile spasms | 3 |
infants children | 2 |
infants should | 4 |
infarction causes | 2 |
infarction presenting | 2 |
infected patients | 7 |
infected substance | 3 |
infection offered | 2 |
infection patients | 4 |
infection prior | 2 |
infection should | 3 |
infection sufficient | 2 |
infections after | 2 |
infections associated | 2 |
infections should | 9 |
inflamed epidermoid | 2 |
influenza vaccine | 4 |
inform patients | 2 |
information about | 6 |
information obtained | 2 |
information regarding | 4 |
informed discussion | 6 |
infused positive | 2 |
inguinal hernia | 2 |
inhaled colistin | 2 |
inhaled corticosteroids | 4 |
inhibition reninangiotensin | 2 |
inhibitor should | 2 |
inhibitor therapy | 5 |
inhibitors anastrozole | 2 |
inhibitors arbs | 3 |
inhibitors firstline | 2 |
inhibitors recommended | 2 |
inhibitors should | 2 |
initial evaluation | 3 |
initial laboratory | 2 |
initial subsequent | 2 |
initial therapy | 4 |
initial treatment | 11 |
initial visit | 2 |
initiate antibiotic | 4 |
initiated soon | 2 |
initiation npep | 2 |
initiation therapy | 2 |
injuries animal | 2 |
inotropic agents | 3 |
inotropic drugs | 2 |
inotropic support | 4 |
institutions should | 3 |
insufficient data | 5 |
insufficient evidence | 22 |
insufficient recommend | 8 |
intensive care | 5 |
interactions other | 2 |
interest patient | 3 |
intermediate highrisk | 2 |
intermediate risk | 2 |
international classification | 2 |
international normalized | 4 |
interpretation serum | 2 |
interval between | 3 |
interventions promote | 4 |
interventions reduce | 2 |
into account | 11 |
into routine | 2 |
intolerant inhibitors | 3 |
intracranial pressure | 3 |
intraoperatively continued | 2 |
intraoral devices | 3 |
intrauterine pregnancy | 2 |
intravenous antibiotic | 2 |
intravenous diuretics | 2 |
intravenous fluids | 2 |
intravenous immunoglobulin | 3 |
intravenous inotropic | 4 |
intravenous loop | 2 |
invasive hemodynamic | 3 |
invasive procedure | 2 |
involvement members | 2 |
iron deficiency | 2 |
ischemic attack | 2 |
ischemic heart | 2 |
isolate susceptible | 3 |
isolated adrenal | 2 |
isolates methicillin | 3 |
isolates resistant | 2 |
isosorbide dinitrate | 4 |
jointly individual | 3 |
judgment patient | 2 |
jugular venous | 2 |
juvenile justice | 2 |
known suspected | 2 |
laar active | 2 |
laboratory blood | 3 |
laboratory tests | 3 |
lacking features | 2 |
laparoscopic open | 2 |
laparoscopic surgery | 4 |
last dose | 3 |
last five | 2 |
lasting hours | 2 |
later than | 2 |
lbbb duration | 2 |
lbbb pattern | 5 |
lduh lmwh | 2 |
le brain | 3 |
lead levels | 3 |
leads greater | 2 |
leads lacking | 2 |
least annually | 2 |
least every | 4 |
least hours | 2 |
least weeks | 2 |
least year | 2 |
left atrial | 2 |
left atypical | 2 |
left ventricular | 6 |
lesions impetigo | 2 |
lesions should | 2 |
less than | 16 |
letrozole in | 2 |
leukemia fludarabine | 2 |
level quality | 2 |
level should | 3 |
levels asymptomatic | 3 |
levels renal | 2 |
levels should | 3 |
levofloxacin imipenem | 3 |
licensed indications | 6 |
life expectancy | 4 |
life support | 4 |
lifestyle changes | 2 |
limb leads | 2 |
limb tremor | 3 |
limited evidence | 2 |
limitedstage small | 2 |
line treatment | 2 |
linezolid daptomycin | 2 |
linezolid rather | 2 |
lipid formulation | 3 |
lipid profile | 4 |
lipoprotein cholesterol | 5 |
list differential | 2 |
live birth | 2 |
liver biopsy | 3 |
liver disease | 3 |
liver enzymeinducing | 3 |
liver function | 5 |
liver transplantation | 4 |
liver ultrasonography | 3 |
lmwh prophylaxis | 2 |
local poison | 2 |
local systemic | 2 |
local treatment | 2 |
locally advanced | 7 |
longer than | 2 |
longterm infused | 2 |
longterm outcomes | 3 |
loop diuretic | 2 |
loop diuretics | 2 |
loss obese | 2 |
loss should | 3 |
lower rate | 2 |
lower risk | 3 |
lumbar fusion | 5 |
lumbar stenosis | 3 |
lung cancer | 31 |
luteal phase | 2 |
luteinizing hormone | 2 |
lvef less | 2 |
lvef sinus | 4 |
lymph node | 2 |
lymph nodes | 6 |
lymphocyte counts | 2 |
lymphocytic leukemia | 3 |
m continued | 2 |
m erlotinib | 2 |
m liver | 2 |
m other | 2 |
m potassium | 2 |
m results | 2 |
m symptoms | 2 |
m there | 5 |
m2 over | 3 |
macular degeneration | 3 |
made after | 3 |
made available | 3 |
made jointly | 3 |
magnetic resonance | 9 |
maintain systemic | 2 |
maintenance exam | 2 |
make recommendation | 2 |
makers commissioners | 2 |
malicious administration | 3 |
malignancy chemotherapy | 3 |
mammography clinical | 3 |
managed nonoperatively | 2 |
management comorbid | 2 |
management diabetes | 2 |
management patients | 2 |
management recommendations | 2 |
management should | 2 |
management these | 2 |
many cases | 2 |
many patients | 2 |
mass ultrasonography | 2 |
massive haemorrhage | 2 |
material should | 2 |
maternal fetal | 3 |
maximum tolerated | 2 |
meaningful survival | 3 |
means assess | 2 |
measurement serum | 3 |
media effusion | 4 |
mediastinal lymph | 3 |
mediastinal node | 2 |
medical conditions | 4 |
medical management | 2 |
medical psychosocial | 2 |
medical record | 3 |
medical records | 2 |
medical surgical | 5 |
medical therapy | 11 |
medical treatment | 3 |
medication should | 2 |
meet criteria | 2 |
members appropriate | 2 |
members should | 2 |
mental health | 4 |
mental status | 4 |
meropenem oxacillin | 2 |
metabolic acidosis | 2 |
metastatic breast | 6 |
metastatic disease | 3 |
methicillin resistant | 3 |
micrograms every | 2 |
microscopic examination | 2 |
microscopic hematuria | 3 |
midline shift | 2 |
might considered | 2 |
might occur | 2 |
might reduce | 2 |
mild moderate | 3 |
millivolts more | 2 |
minutes after | 2 |
mitral valve | 2 |
moderate severe | 4 |
molecular weight | 2 |
molecularweight heparin | 2 |
monitor patient | 2 |
monitoring arterial | 2 |
monitoring techniques | 2 |
monotherapy recommended | 2 |
month period | 2 |
months after | 4 |
months months | 2 |
morbidity mortality | 17 |
more common | 3 |
more contiguous | 3 |
more effective | 2 |
more following | 2 |
more frequently | 2 |
more likely | 2 |
more patients | 2 |
more positive | 2 |
more severe | 2 |
more than | 13 |
more thorough | 2 |
mortality patients | 5 |
mortality recommended | 2 |
mortality selected | 2 |
mortality suggest | 3 |
most commonly | 3 |
most effective | 5 |
most important | 3 |
most instances | 2 |
most likely | 5 |
most patients | 3 |
most women | 2 |
mrsa infection | 4 |
mrsa known | 2 |
mssa necessary | 4 |
mucor rhizopus | 2 |
multidisciplinary team | 5 |
multidose vials | 2 |
muscle strength | 3 |
must given | 2 |
myocardial infarction | 3 |
myocardial ischemia | 2 |
myocardial perfusion | 3 |
myocardium present | 2 |
nafcillin cefazolin | 4 |
nasal colonization | 2 |
national academy | 2 |
natriuretic peptide | 5 |
natural history | 2 |
necessary empiric | 4 |
necessary when | 2 |
necrotizing fasciitis | 3 |
needed education | 2 |
needed patients | 2 |
negative scanning | 2 |
neurodevelopmental outcome | 2 |
neuroimaging should | 2 |
neuroimaging study | 2 |
neurologic examination | 4 |
neuromuscular blocking | 3 |
neutropenia severe | 2 |
newborn screening | 4 |
nitrogen creatinine | 2 |
node involvement | 2 |
nodes found | 2 |
nonasthmatic eosinophilic | 3 |
noninvasive sampling | 2 |
nonsteroidal antiinflammatory | 3 |
normal range | 3 |
normalized ratio | 4 |
north america | 2 |
nsclc biopsy | 2 |
nuclear medicine | 2 |
nurses develop | 2 |
nurses know | 2 |
nurses practice | 2 |
nurses will | 5 |
nursing best | 2 |
nutrition assessment | 3 |
nutrition board | 2 |
nutrition screening | 2 |
nutrition should | 2 |
nutrition support | 2 |
nutrition training | 2 |
nutritional supplements | 3 |
nyha class | 27 |
obese adults | 2 |
obese women | 2 |
obscuring segment | 2 |
observed home | 2 |
obstetric cholestasis | 2 |
obstetricians should | 2 |
obstructive pulmonary | 3 |
obtain history | 2 |
occult blood | 2 |
occupational asthma | 2 |
occur between | 2 |
occur patient | 2 |
occur result | 2 |
offered choice | 2 |
offered surgical | 2 |
offered trial | 2 |
office setting | 2 |
officebased practices | 2 |
older children | 2 |
older people | 2 |
older person | 3 |
older persons | 2 |
older than | 2 |
once daily | 3 |
once weekly | 2 |
oncology group | 2 |
ongoing clinical | 2 |
ongoing education | 2 |
ongoing opportunities | 2 |
only endorse | 2 |
only patients | 3 |
only polymyxins | 4 |
only there | 2 |
onset reveals | 3 |
open laparoscopic | 3 |
open surgery | 3 |
operable nsclc | 2 |
operative intervention | 2 |
opinion treating | 2 |
opportunities discussion | 2 |
option after | 2 |
option patients | 4 |
option secondline | 2 |
option when | 2 |
option women | 2 |
options include | 2 |
options potential | 2 |
options should | 2 |
oral anticoagulation | 3 |
oral corticosteroids | 2 |
oral health | 3 |
oral penicillin | 3 |
oral such | 3 |
oral therapy | 2 |
organ dysfunction | 2 |
organizational readiness | 2 |
organizations should | 2 |
original guideline | 6 |
orthopaedic surgeon | 2 |
other airflow | 2 |
other antihypertensive | 2 |
other cardiovascular | 2 |
other clinical | 2 |
other conditions | 2 |
other gramnegative | 3 |
other indication | 2 |
other indications | 2 |
other medications | 2 |
other risk | 3 |
other than | 6 |
other treatment | 2 |
other treatments | 4 |
otherwise considered | 2 |
otitis media | 4 |
out additional | 2 |
out concomitant | 2 |
out prior | 4 |
out risk | 2 |
out symptoms | 2 |
outcome following | 2 |
outcome patients | 2 |
outcome prognosis | 2 |
outcomes patients | 2 |
outpatient procedure | 2 |
outpatient setting | 2 |
outpatient therapy | 2 |
outside clinical | 5 |
ovarian cancer | 2 |
over best | 2 |
over first | 2 |
over hour | 3 |
over month | 2 |
over standard | 3 |
over years | 2 |
overall survival | 7 |
overall wellbeing | 2 |
overload should | 2 |
overweight obesity | 3 |
ovulation induction | 2 |
oxacillin nafcillin | 4 |
oxygen therapy | 3 |
paclitaxel m2 | 2 |
pain caused | 2 |
pain children | 2 |
pain common | 2 |
pain important | 2 |
pain relief | 3 |
palliation patients | 2 |
palliative care | 4 |
palliative effects | 2 |
panel recommends | 4 |
parameter recommended | 2 |
parameters assessment | 2 |
parapsilosis been | 2 |
parenteral nutrition | 4 |
parents should | 3 |
parents teachers | 2 |
parenttraining education | 2 |
paroxysmal out | 2 |
paroxysmal should | 2 |
part baseline | 3 |
part properly | 2 |
part routine | 4 |
part their | 3 |
partial seizures | 2 |
particular attention | 3 |
particularly important | 2 |
particularly patients | 2 |
pathogen sensitive | 2 |
pathological stage | 2 |
patient been | 5 |
patient care | 2 |
patient chronic | 2 |
patient education | 4 |
patient experiences | 2 |
patient family | 3 |
patient fully | 3 |
patient greater | 2 |
patient interview | 2 |
patient m2 | 3 |
patient management | 3 |
patient more | 2 |
patient needs | 5 |
patient otherwise | 2 |
patient parent | 2 |
patient practitioner | 2 |
patient preference | 4 |
patient results | 2 |
patient should | 5 |
patient time | 2 |
patient understand | 2 |
patient'medical record | 2 |
patients able | 2 |
patients acute | 10 |
patients admitted | 2 |
patients advanced | 8 |
patients aeruginosa | 5 |
patients after | 2 |
patients already | 3 |
patients apparent | 3 |
patients asthma | 2 |
patients asymptomatic | 2 |
patients been | 2 |
patients being | 9 |
patients candidates | 3 |
patients cannot | 2 |
patients carers | 2 |
patients caused | 7 |
patients cd | 2 |
patients chronic | 17 |
patients clinical | 3 |
patients considered | 2 |
patients contraindications | 2 |
patients cough | 6 |
patients critical | 3 |
patients cryptogenic | 2 |
patients current | 7 |
patients currently | 3 |
patients dementia | 3 |
patients develop | 2 |
patients diabetes | 5 |
patients diagnosis | 2 |
patients diffuse | 2 |
patients eastern | 2 |
patients especially | 2 |
patients fail | 2 |
patients failed | 2 |
patients families | 2 |
patients following | 4 |
patients gdmt | 2 |
patients good | 3 |
patients hfpef | 9 |
patients hfref | 18 |
patients high | 5 |
patients history | 2 |
patients hypertension | 3 |
patients include | 2 |
patients increased | 2 |
patients infected | 2 |
patients intermediate | 5 |
patients less | 2 |
patients locally | 3 |
patients lumbar | 2 |
patients lung | 2 |
patients lvef | 9 |
patients m | 12 |
patients malignancy | 2 |
patients mild | 3 |
patients moderate | 3 |
patients more | 3 |
patients nyha | 7 |
patients observed | 2 |
patients out | 6 |
patients parkinson'disease | 3 |
patients patients | 2 |
patients persistent | 6 |
patients poor | 2 |
patients positive | 2 |
patients present | 2 |
patients presenting | 12 |
patients preterm | 2 |
patients previous | 2 |
patients previously | 2 |
patients prior | 2 |
patients raised | 2 |
patients receiving | 6 |
patients recent | 3 |
patients recently | 2 |
patients recommend | 2 |
patients recommended | 2 |
patients recurrent | 2 |
patients reduced | 3 |
patients referred | 3 |
patients refractory | 2 |
patients report | 2 |
patients require | 4 |
patients requiring | 2 |
patients respond | 3 |
patients risk | 6 |
patients se | 5 |
patients severe | 8 |
patients should | 23 |
patients single | 2 |
patients sirs | 2 |
patients small | 2 |
patients stage | 11 |
patients studies | 2 |
patients suggest | 4 |
patients suspected | 18 |
patients symptomatic | 6 |
patients symptoms | 5 |
patients their | 4 |
patients those | 2 |
patients undergoing | 15 |
patients undergone | 3 |
patients unexplained | 2 |
patients unintentional | 2 |
patients units | 2 |
patients unless | 3 |
pattern duration | 4 |
pcos unknown | 2 |
pediatric cancer | 2 |
pediatric dtap | 2 |
pediatric patients | 2 |
pediatricians should | 9 |
peer support | 2 |
peginterferon alfa2a | 2 |
people diabetes | 2 |
people m | 2 |
people should | 2 |
people symptoms | 2 |
peptide biomarkers | 2 |
perform physical | 2 |
perform procedure | 2 |
perform transvaginal | 2 |
performance measures | 2 |
performance status | 11 |
performanceenhancing substances | 2 |
performed every | 2 |
performed in | 2 |
performed patients | 4 |
perfusion preserve | 2 |
perfusion spect | 2 |
pericarditis left | 2 |
perioperative visual | 2 |
peripheral lesion | 2 |
peripheral neuropathies | 2 |
permanent persistent | 5 |
persistent paroxysmal | 5 |
persistent symptoms | 2 |
persistently symptomatic | 2 |
personnel should | 3 |
persons increased | 3 |
persons should | 2 |
pertussis they | 3 |
pertussis vaccination | 2 |
pharmacological management | 2 |
phase study | 2 |
physical activities | 2 |
physical activity | 11 |
physical exam | 4 |
physical examination | 9 |
physical factors | 2 |
physician should | 2 |
physicians dietitians | 2 |
physicians should | 2 |
piperacillintazobactam cefepime | 3 |
placed intraoperatively | 2 |
plan care | 3 |
plan implementation | 2 |
planning pregnancy | 2 |
platinumbased chemotherapy | 4 |
plus clinical | 4 |
plus either | 2 |
pneumatic compression | 3 |
pneumococcal vaccine | 3 |
poison center | 2 |
policies should | 2 |
policies they | 2 |
policy makers | 3 |
polymyxins recommend | 2 |
polymyxins suggest | 2 |
polyp diagnosed | 2 |
poorly tolerated | 2 |
population being | 2 |
poses substantial | 2 |
positive airway | 2 |
positive inotropic | 3 |
positive scanning | 2 |
positron emission | 2 |
possible advance | 2 |
possible treatment | 2 |
possibly indicated | 2 |
post lvef | 3 |
postexposure prophylaxis | 2 |
postherpetic neuralgia | 2 |
postmenopausal bleeding | 2 |
postmenopausal women | 3 |
postoperative pulmonary | 3 |
postoperatively until | 2 |
postpartum period | 2 |
potential benefits | 2 |
potential drug | 3 |
potential side | 2 |
potential toxicity | 2 |
potentially harmful | 7 |
potentially malicious | 2 |
potentially resectable | 2 |
practice guideline | 2 |
practice guidelines | 5 |
practice settings | 3 |
practitioner patient | 2 |
practitioners policy | 2 |
practitioners should | 4 |
preclude biopsy | 2 |
precordial leads | 2 |
predict outcome | 3 |
predictive outcome | 2 |
predisposing factors | 4 |
preference potential | 2 |
preferred agents | 2 |
preferred over | 2 |
preferred treatment | 2 |
pregnancy loss | 2 |
pregnancy should | 2 |
pregnant patients | 4 |
pregnant women | 5 |
premature ejaculation | 2 |
premature rupture | 2 |
preoperative tests | 3 |
prescribed gdmt | 2 |
prescribed solely | 2 |
prescribing antibiotic | 4 |
prescribing antibiotics | 2 |
presence absence | 3 |
presence lung | 3 |
presence severe | 2 |
presentation strongly | 2 |
presenting acute | 2 |
presenting in | 3 |
pressure controlled | 2 |
pressure mmhg | 2 |
pressure remains | 3 |
pressure should | 2 |
pressure significant | 2 |
pressure ulcers | 4 |
prevalence mrsa | 2 |
prevent sudden | 3 |
prevent symptomatic | 5 |
prevention drawal | 2 |
prevention services | 2 |
prevention treatment | 3 |
preventive services | 4 |
previous cesarean | 4 |
previous liver | 2 |
previous months | 2 |
previously received | 5 |
previously treated | 2 |
primarily consensus | 2 |
primary care | 12 |
primary cause | 2 |
primary goal | 2 |
primary prevention | 3 |
primary target | 2 |
prior current | 2 |
prior discharge | 2 |
prior histological | 2 |
prior intravenous | 2 |
prior symptoms | 7 |
prior thromboembolic | 2 |
problems should | 2 |
procedural sedation | 2 |
procedure choice | 5 |
procedure endoscopic | 2 |
process ongoing | 2 |
products conception | 2 |
professional development | 2 |
professional expertise | 2 |
professional further | 2 |
professionals should | 3 |
profiles individual | 2 |
prognostic factor | 2 |
programme in | 2 |
programs should | 2 |
promote physical | 2 |
promote sustained | 3 |
properly designed | 2 |
prophylactic antibiotics | 2 |
prophylactic oophorectomy | 2 |
pros cons | 2 |
prosthetic heart | 2 |
protect against | 4 |
protection infection | 2 |
protocol recommended | 2 |
proton pump | 2 |
proven mssa | 4 |
proven reduce | 2 |
provide information | 3 |
provide support | 3 |
providers should | 4 |
psoriasis responded | 2 |
psychiatric consultation | 2 |
psychological therapy | 2 |
psychotropic medications | 2 |
public health | 2 |
public private | 3 |
published clinical | 3 |
pulmonary complications | 3 |
pulmonary disease | 4 |
pulmonary function | 3 |
pump inhibitor | 2 |
qualified healthcare | 2 |
qualified individual | 2 |
qualified provider | 2 |
quality care | 2 |
quality control | 2 |
quality evidence | 3 |
quality improvement | 3 |
quality life | 12 |
quantitative cultures | 2 |
questions into | 2 |
quitting smoking | 2 |
radiation therapy | 10 |
radiograph findings | 2 |
radiographically enlarged | 2 |
radiography indicated | 2 |
radiography recommended | 2 |
radiotherapy fractions | 2 |
radiotherapy recommended | 2 |
radiotherapy should | 2 |
radiotherapy unknown | 2 |
randomised controlled | 3 |
randomized controlled | 7 |
randomized phase | 2 |
range patient | 2 |
rate beats | 2 |
rate breaths | 2 |
rate m | 2 |
rather than | 18 |
ratio therapeutic | 2 |
reaction chicken | 2 |
readily available | 2 |
readiness barriers | 2 |
ready access | 2 |
reasonable adjunctive | 2 |
reasonable alternative | 2 |
reasonable bridge | 2 |
reasonable expectation | 3 |
reasonable improve | 4 |
reasonable patients | 10 |
reasonable treatment | 4 |
reasonable typical | 2 |
rebleeding patients | 2 |
receive appropriate | 3 |
receive chemotherapy | 2 |
receive dose | 2 |
receive doses | 2 |
receive education | 2 |
receive single | 4 |
received anthracycline | 2 |
recent remote | 3 |
recently received | 2 |
receptor antagonists | 5 |
receptorneprilysin inhibitor | 2 |
recommend against | 13 |
recommend choice | 2 |
recommend course | 2 |
recommend intravenous | 2 |
recommend prescribing | 2 |
recommend treatment | 5 |
recommend using | 5 |
recommendation against | 2 |
recommendation made | 2 |
recommendation practitioners | 2 |
recommendation very | 3 |
recommendations assess | 2 |
recommendations based | 3 |
recommendationsthere insufficient | 3 |
recommended after | 2 |
recommended alternative | 2 |
recommended because | 5 |
recommended child | 3 |
recommended childhood | 2 |
recommended children | 3 |
recommended clinical | 2 |
recommended determine | 2 |
recommended dose | 2 |
recommended duration | 2 |
recommended either | 2 |
recommended following | 2 |
recommended help | 2 |
recommended initial | 3 |
recommended management | 2 |
recommended means | 3 |
recommended mediastinal | 2 |
recommended milrinone | 2 |
recommended older | 2 |
recommended option | 2 |
recommended options | 3 |
recommended orthopaedic | 2 |
recommended outside | 2 |
recommended part | 2 |
recommended patients | 44 |
recommended primary | 2 |
recommended reasonable | 2 |
recommended reduce | 3 |
recommended regimens | 2 |
recommended routine | 8 |
recommended safe | 2 |
recommended treatment | 19 |
recommended when | 2 |
recommended women | 3 |
recommends against | 5 |
recommends clinicians | 3 |
recommends following | 2 |
recommends screening | 2 |
recording possibly | 2 |
recurrent abscess | 2 |
recurrent abscesses | 2 |
recurrent miscarriage | 3 |
recurrent pregnancy | 2 |
recurrent progressive | 2 |
reduce congestive | 2 |
reduce incidence | 6 |
reduce morbidity | 15 |
reduce mortality | 5 |
reduce risk | 4 |
reduce total | 2 |
reduced prevent | 2 |
reducing incidence | 2 |
refer patients | 3 |
referral should | 2 |
referred emergency | 6 |
referred multidisciplinary | 2 |
referred secondary | 2 |
referred trained | 2 |
referred transplant | 2 |
reflux disease | 2 |
regimen including | 3 |
regular intervals | 4 |
regular physical | 2 |
regularly frequency | 2 |
reinforce importance | 2 |
related insufficient | 2 |
related macular | 3 |
relief symptoms | 2 |
remote history | 3 |
renal disease | 2 |
renal dysfunction | 3 |
renal function | 8 |
renal impairment | 2 |
renal insufficiency | 3 |
renal transplantation | 2 |
reninangiotensin system | 2 |
repeat measurement | 2 |
replacement therapy | 3 |
repolarization pericarditis | 2 |
requesting protection | 2 |
require further | 2 |
require specific | 2 |
required before | 2 |
required confirm | 2 |
requires biopsy | 2 |
research should | 2 |
research study | 2 |
resection margins | 2 |
reserved patients | 4 |
resistance being | 2 |
resistant agent | 2 |
resonance imaging | 9 |
resources available | 2 |
respiratory rate | 2 |
responded adequately | 2 |
response rate | 2 |
response therapy | 4 |
responsible treatment | 3 |
restriction reasonable | 2 |
results antibiotic | 2 |
results antimicrobial | 2 |
results recommendations | 2 |
retinal findings | 2 |
reuptake inhibitors | 2 |
revascularization coronary | 2 |
reveals elevations | 2 |
rhizopus infections | 2 |
rhythm lbbb | 5 |
right left | 2 |
ripening induction | 2 |
risk assessment | 5 |
risk cardiac | 2 |
risk coronary | 2 |
risk death | 3 |
risk developing | 7 |
risk development | 3 |
risk developmental | 2 |
risk factor | 9 |
risk factors | 31 |
risk fractures | 2 |
risk having | 2 |
risk infection | 4 |
risk mortality | 4 |
risk patients | 5 |
risk postoperative | 3 |
risk recurrence | 4 |
risk recurrent | 2 |
risk stratification | 2 |
risk syphilis | 2 |
risk transmission | 3 |
risk transmitting | 2 |
risk treatment | 2 |
risks associated | 3 |
risks benefits | 7 |
risks potential | 2 |
risky behavior | 2 |
routine breast | 3 |
routine clinical | 2 |
routine evaluation | 3 |
routine patient | 2 |
routine screening | 7 |
routine tdap | 2 |
routine therapy | 2 |
routine treatment | 2 |
rule metastatic | 2 |
rupture membranes | 3 |
safe effective | 3 |
safety efficacy | 3 |
salvage therapy | 2 |
sampling semiquantitative | 2 |
satellite unit | 2 |
scan greater | 2 |
scan patients | 2 |
scan requires | 2 |
scan scan | 2 |
scanning does | 2 |
scanning liver | 2 |
scanning negative | 2 |
scanning recommended | 3 |
schemes promote | 2 |
school personnel | 2 |
schoolbased mental | 2 |
schools should | 4 |
scientific evidence | 2 |
screen presence | 4 |
screening children | 3 |
screening elevated | 3 |
screening patients | 2 |
screening programs | 2 |
screening questions | 2 |
screening should | 5 |
screening test | 5 |
screening treatment | 2 |
secondary care | 2 |
secondary prevention | 3 |
secondary sarcoidosis | 2 |
secondline subsequent | 2 |
secondline therapy | 6 |
sedation analgesia | 2 |
segment analysis | 2 |
segment elevation | 2 |
select patients | 2 |
selected patients | 16 |
selected symptomatic | 2 |
selection anticoagulant | 2 |
selective serotonin | 2 |
selfharm victims | 2 |
semiquantitative cultures | 2 |
sensitive only | 5 |
septic shock | 3 |
serologic testing | 2 |
serotonin reuptake | 3 |
serum albumin | 2 |
serum alphafetoprotein | 2 |
serum assay | 2 |
serum creatinine | 4 |
serum electrolytes | 3 |
serum human | 2 |
serum level | 2 |
service should | 2 |
services task | 4 |
setting should | 2 |
settings should | 2 |
seven days | 2 |
severe cellmediated | 2 |
severe infections | 2 |
severe insomnia | 2 |
severe renal | 2 |
severe systolic | 3 |
sexual assault | 2 |
sexually active | 3 |
shock high | 2 |
shock should | 2 |
short course | 2 |
shortest transverse | 2 |
shortterm treatment | 3 |
should added | 4 |
should address | 2 |
should administered | 12 |
should advised | 8 |
should advocated | 2 |
should also | 8 |
should always | 3 |
should appropriately | 2 |
should assess | 5 |
should assessed | 2 |
should attempted | 3 |
should available | 2 |
should avoided | 2 |
should aware | 5 |
should based | 11 |
should become | 2 |
should begin | 2 |
should carried | 2 |
should clear | 2 |
should conduct | 2 |
should consider | 7 |
should considered | 58 |
should consulted | 2 |
should continue | 2 |
should continued | 3 |
should controlled | 4 |
should counseled | 7 |
should decontaminated | 2 |
should defined | 2 |
should desensitized | 2 |
should determined | 7 |
should developed | 3 |
should discussed | 4 |
should done | 6 |
should effective | 2 |
should encourage | 2 |
should encouraged | 5 |
should ensure | 4 |
should established | 2 |
should evaluated | 10 |
should familiar | 2 |
should first | 2 |
should focus | 2 |
should follow | 4 |
should followed | 4 |
should fully | 2 |
should given | 9 |
should identified | 3 |
should immunized | 3 |
should include | 20 |
should included | 3 |
should individualized | 6 |
should inform | 2 |
should informed | 4 |
should initiated | 7 |
should instituted | 4 |
should instructed | 2 |
should involve | 2 |
should lead | 2 |
should limited | 2 |
should made | 14 |
should maintain | 2 |
should managed | 3 |
should measured | 3 |
should monitored | 9 |
should never | 2 |
should normally | 2 |
should obtained | 11 |
should occur | 9 |
should offered | 16 |
should only | 7 |
should part | 3 |
should participate | 3 |
should perform | 2 |
should performed | 29 |
should prepared | 2 |
should prescribed | 8 |
should promote | 2 |
should prompt | 2 |
should promptly | 2 |
should provide | 4 |
should provided | 2 |
should receive | 26 |
should refer | 3 |
should referred | 20 |
should reserved | 4 |
should reviewed | 5 |
should routinely | 4 |
should screened | 6 |
should started | 2 |
should support | 2 |
should suspected | 4 |
should take | 7 |
should taken | 6 |
should then | 2 |
should told | 2 |
should trained | 2 |
should treated | 17 |
should undergo | 10 |
should undertaken | 2 |
should used | 48 |
should usually | 3 |
side effects | 10 |
sideeffect profile | 2 |
sideeffect profiles | 3 |
sigmoidoscopy every | 2 |
significant change | 2 |
significant effect | 2 |
significant maternal | 2 |
significant risk | 2 |
significant signs | 2 |
significantly affect | 2 |
significantly depressed | 2 |
signs increased | 2 |
signs infection | 4 |
signs symptoms | 7 |
single dose | 6 |
singleagent anthracycline | 2 |
singleagent docetaxel | 4 |
sinus rhythm | 8 |
site infections | 3 |
situations informed | 2 |
situations there | 2 |
skin lesions | 7 |
skin soft | 6 |
sleep apnea | 2 |
sleep quality | 2 |
small cell | 14 |
small number | 2 |
soap water | 2 |
social factors | 2 |
sodium restriction | 2 |
soft tissue | 6 |
some cases | 3 |
some specialists | 3 |
soon possible | 7 |
special attention | 3 |
specialists recommend | 2 |
species sensitive | 3 |
specific clinical | 2 |
specific diagnosis | 2 |
specific indications | 3 |
specific risk | 2 |
specific treatment | 4 |
spinal cord | 2 |
spinal instability | 2 |
spontaneous labor | 2 |
sports should | 2 |
sputum cytology | 2 |
sputum production | 2 |
stabilized standard | 2 |
stable patients | 5 |
stage despite | 2 |
stage disease | 2 |
stage hfref | 2 |
stage iiia | 3 |
stage nsclc | 3 |
stage refractory | 2 |
stage small | 3 |
stage tumours | 2 |
staging distant | 2 |
staging locoregional | 2 |
staging patients | 2 |
stain culture | 6 |
stand against | 2 |
standard combination | 2 |
standard medical | 2 |
standard radiotherapy | 3 |
staphylococcus aureus | 4 |
start treatment | 2 |
states should | 2 |
statins beneficial | 2 |
status before | 2 |
status following | 2 |
step patient | 2 |
strategy inhibition | 2 |
strength function | 2 |
streptomycin q12h | 2 |
stroke death | 3 |
stroke patients | 3 |
strong stand | 2 |
strongly encouraged | 2 |
strongly recommended | 2 |
strongly recommends | 4 |
strongly suggestive | 2 |
strongly supported | 2 |
studies needed | 2 |
studies patients | 2 |
studies show | 2 |
study determine | 2 |
study done | 3 |
subsequent treatment | 3 |
substance disorders | 2 |
substance users | 3 |
substantial risk | 2 |
successful vaginal | 2 |
such children | 2 |
such edema | 2 |
such temperature | 2 |
such those | 3 |
such warfarin | 3 |
sudden cardiac | 3 |
sufficient impair | 2 |
suggest adjunctive | 2 |
suggest antibiotic | 2 |
suggest avoiding | 2 |
suggest clinicians | 3 |
suggest including | 2 |
suggest prescribing | 5 |
suggest regimen | 3 |
suggest using | 4 |
suggestive acute | 3 |
suitable patients | 2 |
supplemental oxygen | 2 |
supplementation been | 2 |
supplementation reasonable | 2 |
supplements treatment | 2 |
support breastfeeding | 2 |
support needed | 3 |
support reasonable | 2 |
support refute | 4 |
support should | 3 |
support training | 2 |
supportive care | 7 |
supportive function | 2 |
supports dexrazoxane | 2 |
suppurative airways | 2 |
surgeon must | 2 |
surgeon should | 2 |
surgery center | 2 |
surgery colon | 2 |
surgery continued | 2 |
surgery recommended | 4 |
surgery should | 5 |
surgical debridement | 3 |
surgical intervention | 2 |
surgical management | 2 |
surgical procedures | 2 |
surgical resection | 6 |
surgical site | 3 |
surgical staging | 3 |
surgical treatment | 4 |
surveillance colonoscopy | 2 |
surveillance patients | 2 |
survival advantage | 2 |
survival good | 2 |
survival over | 2 |
survival patients | 4 |
survival should | 2 |
susceptibility testing | 4 |
susceptible rather | 2 |
suspected confirmed | 4 |
suspected having | 5 |
suspected only | 2 |
suspected patients | 2 |
suspected recommend | 4 |
suspected selfharm | 3 |
suspected suggest | 4 |
suspicious lung | 2 |
sustained weight | 4 |
sustainedrelease preparation | 2 |
symptom control | 2 |
symptom onset | 3 |
symptomatic even | 2 |
symptomatic hfref | 2 |
symptomatic patients | 7 |
symptomatic reduce | 2 |
symptomatic stenosis | 2 |
symptoms after | 2 |
symptoms associated | 2 |
symptoms chronic | 3 |
symptoms despite | 2 |
symptoms drawal | 2 |
symptoms gdmt | 5 |
symptoms hfref | 6 |
symptoms history | 4 |
symptoms signs | 2 |
symptoms suggestive | 3 |
syndrome cannot | 2 |
syndrome reduced | 2 |
synthetic materials | 2 |
syphilis infection | 3 |
systemic antibiotics | 2 |
systemic antimicrobial | 2 |
systemic chemotherapy | 2 |
systemic corticosteroids | 2 |
systemic perfusion | 3 |
systemic signs | 4 |
systems care | 2 |
systolic blood | 4 |
systolic diastolic | 3 |
systolic dysfunction | 6 |
table below | 2 |
table original | 2 |
table patients | 3 |
take into | 6 |
take place | 2 |
taken fully | 2 |
taking into | 2 |
taking warfarin | 2 |
tamoxifen therapy | 3 |
target range | 4 |
task force | 11 |
tdap vaccination | 2 |
tdap vaccine | 2 |
team members | 2 |
team should | 2 |
technically impossible | 2 |
temperature degrees | 2 |
test diagnose | 4 |
test results | 2 |
test should | 2 |
testing known | 2 |
testosterone levels | 2 |
testosterone therapy | 4 |
tests negative | 2 |
tetanus diphtheria | 4 |
tetanus toxoids | 2 |
than cm3 | 2 |
than correct | 2 |
than equal | 4 |
than every | 2 |
than hours | 3 |
than laar | 2 |
than months | 2 |
than seven | 2 |
than shortest | 2 |
than using | 4 |
than weeks | 3 |
than years | 9 |
their clinical | 2 |
their families | 3 |
their health | 2 |
their individual | 2 |
their initial | 2 |
their licensed | 4 |
their partners | 2 |
their risk | 3 |
their s | 2 |
their safety | 2 |
their treatment | 2 |
therapeutic option | 3 |
therapeutic range | 3 |
therapies other | 2 |
therapy amphotericin | 2 |
therapy appropriate | 3 |
therapy based | 4 |
therapy cannot | 3 |
therapy choice | 3 |
therapy combination | 3 |
therapy considered | 2 |
therapy days | 2 |
therapy dose | 2 |
therapy either | 3 |
therapy eligible | 2 |
therapy hfref | 3 |
therapy indicated | 4 |
therapy inhibitors | 2 |
therapy m | 3 |
therapy most | 2 |
therapy need | 2 |
therapy nursing | 2 |
therapy oral | 3 |
therapy out | 3 |
therapy patients | 13 |
therapy rather | 2 |
therapy reasonable | 2 |
therapy recommended | 9 |
therapy should | 15 |
therapy when | 3 |
therapy women | 4 |
there clinical | 4 |
there current | 3 |
there data | 4 |
there evidence | 7 |
there insufficient | 18 |
there limitations | 2 |
there limited | 2 |
there small | 2 |
therefore recommended | 4 |
therefore should | 2 |
these agents | 2 |
these conditions | 5 |
these infants | 2 |
these patients | 8 |
these treatments | 2 |
they been | 2 |
they history | 3 |
they should | 5 |
thoracic radiotherapy | 3 |
thorough assessment | 2 |
thorough history | 3 |
those patients | 4 |
thought obscuring | 2 |
three four | 2 |
three weeks | 4 |
three years | 3 |
thromboembolic event | 2 |
thromboembolism prophylaxis | 2 |
thyroid function | 4 |
time initial | 2 |
time international | 2 |
time make | 2 |
time period | 2 |
times week | 2 |
tips treat | 2 |
tissue infections | 5 |
titrated attain | 2 |
tolerability patient | 2 |
tolerated dose | 2 |
tomography scan | 4 |
tomography scanning | 2 |
tool predict | 2 |
topical corticosteroid | 2 |
topical corticosteroids | 2 |
total cholesterol | 2 |
total hysterectomy | 2 |
total mortality | 2 |
toxicity mitoxantrone | 2 |
toxoids acellular | 2 |
toxoids vaccine | 2 |
tracheal intubation | 2 |
tract infection | 3 |
tract infections | 2 |
trained healthcare | 2 |
trained personnel | 2 |
training practices | 2 |
training should | 2 |
transabdominal ultrasound | 2 |
transient ischemic | 2 |
transmission others | 3 |
transmitting pertussis | 2 |
transplant center | 2 |
transplant recipients | 3 |
transplantation procedure | 2 |
transplantation should | 2 |
transvaginal ultrasound | 4 |
transverse axis | 2 |
transverse incision | 2 |
trauma patients | 6 |
treated empirically | 7 |
treated icus | 2 |
treating physician | 3 |
treatment above | 2 |
treatment acute | 4 |
treatment asymptomatic | 5 |
treatment choice | 4 |
treatment decision | 2 |
treatment early | 2 |
treatment efalizumab | 2 |
treatment either | 3 |
treatment failure | 3 |
treatment hepatitis | 2 |
treatment includes | 3 |
treatment indicated | 4 |
treatment infantile | 3 |
treatment inhaled | 2 |
treatment methylprednisolone | 2 |
treatment migraine | 2 |
treatment modalities | 3 |
treatment option | 16 |
treatment options | 9 |
treatment oral | 3 |
treatment out | 2 |
treatment patients | 8 |
treatment plan | 2 |
treatment postherpetic | 2 |
treatment proven | 4 |
treatment recommendations | 3 |
treatment recommended | 2 |
treatment regimen | 2 |
treatment regimens | 2 |
treatment should | 20 |
treatment singleagent | 2 |
treatment suspected | 4 |
treatment those | 2 |
treatment treatment | 2 |
treatment waldenstrom'macroglobulinaemia | 2 |
treatments such | 2 |
trial labor | 3 |
trials comparing | 2 |
triglycerides should | 2 |
trivalent inactivated | 2 |
troponin testing | 2 |
twenty years | 2 |
twice daily | 3 |
twice days | 2 |
type devices | 2 |
type diabetes | 6 |
type headache | 2 |
typical cases | 3 |
ultrafiltration considered | 2 |
ultrasonography chest | 3 |
ultrasonography scan | 2 |
ultrasound scan | 2 |
ultrasound used | 2 |
unable tolerate | 4 |
uncertain benefit | 2 |
undergoing elective | 2 |
undergoing gynecologic | 3 |
undergoing previous | 3 |
undergoing transplantation | 2 |
undergone breast | 2 |
undergone resection | 2 |
underlying cause | 2 |
underlying thrombophilia | 2 |
unexplained fever | 2 |
unfractionated heparin | 2 |
unintentional exposure | 2 |
united kingdom | 2 |
united states | 2 |
unless contraindicated | 15 |
unless there | 2 |
unless they | 2 |
unprovoked seizures | 2 |
unresectable stage | 2 |
until discharge | 3 |
until patient | 2 |
upon results | 2 |
urea nitrogen | 3 |
urinary tract | 5 |
used assess | 3 |
used because | 2 |
used conjunction | 2 |
used fractionation | 2 |
used improve | 2 |
used initial | 2 |
used patients | 6 |
used people | 2 |
used prevent | 2 |
used routinely | 2 |
used treatment | 4 |
used when | 2 |
useful assess | 2 |
useful establish | 2 |
useful patients | 6 |
users receiving | 2 |
using clinical | 4 |
using concomitant | 2 |
using cpis | 2 |
using validated | 4 |
uspstf concludes | 5 |
uspstf recommends | 6 |
uspstf strongly | 2 |
uterine bleeding | 3 |
uterine rupture | 2 |
vaccination adults | 2 |
vaccination recommended | 3 |
vaginal birth | 3 |
vaginal bleeding | 3 |
vaginal delivery | 2 |
validated tool | 2 |
valve repair | 2 |
valve replacement | 2 |
vancomycin linezolid | 5 |
vancomycin plus | 3 |
variant dlbcl | 2 |
vascular access | 3 |
vbac should | 2 |
vein thrombosis | 4 |
venous pressure | 2 |
venous thromboembolism | 4 |
venous thrombosis | 2 |
ventricular assist | 2 |
ventricular hypertrophy | 2 |
ventricular pacing | 2 |
very quality | 3 |
viable myocardium | 2 |
vincristine prednisone | 2 |
viral hepatitis | 2 |
viral load | 2 |
virus infected | 3 |
virus infection | 2 |
vision screening | 3 |
visit subsequent | 2 |
visual acuity | 3 |
visual loss | 2 |
vital signs | 2 |
vitamin k1 | 2 |
vitamins minerals | 2 |
volume overload | 4 |
volume status | 3 |
wall motion | 2 |
warfarin dabigatran | 2 |
warfarin should | 2 |
weak recommendation | 2 |
weeks after | 4 |
weeks before | 2 |
weeks gestation | 3 |
weeks months | 2 |
weeks patients | 2 |
weeks postpartum | 2 |
weeks recommended | 2 |
weeks should | 2 |
weight gain | 5 |
weight loss | 15 |
well controlled | 3 |
what give | 2 |
when appropriate | 3 |
when assessing | 4 |
when available | 2 |
when compared | 2 |
when empiric | 3 |
when indicated | 5 |
when more | 2 |
when patient | 3 |
when patients | 2 |
when possible | 2 |
when prescribed | 2 |
when serum | 2 |
when there | 4 |
when treatment | 2 |
whenever possible | 4 |
whether direct | 2 |
whether initiate | 4 |
whether they | 2 |
while taking | 2 |
white blood | 3 |
will advocate | 2 |
will contribute | 2 |
will receive | 5 |
women aged | 2 |
women average | 3 |
women high | 2 |
women m | 3 |
women metastatic | 2 |
women out | 2 |
women pathological | 2 |
women pcos | 4 |
women planning | 2 |
women previous | 4 |
women recurrent | 2 |
women se | 2 |
women should | 9 |
women taking | 3 |
women their | 2 |
women uncomplicated | 2 |
women undergoing | 2 |
women undergone | 2 |
women using | 3 |
work patient | 2 |
world health | 2 |
wound closure | 2 |
written information | 2 |
year life | 2 |
years after | 4 |
years asymptomatic | 2 |
years every | 2 |
years older | 3 |
years presenting | 2 |
years should | 5 |
years when | 2 |
years years | 2 |
york heart | 2 |
young infants | 2 |
younger than | 3 |